Treatment of thromboangiitis obliterans (Buerger's disease) with high‐potency vasodilators

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-8019|28|3|135-139

ISSN： 1396-0296

Source： DERMATOLOGIC THERAPY, Vol.28, Iss.3, 2015-05, pp. : 135-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parkinson's Disease: The Treatment Options.

By Bain P.G.  

Brain, Vol. 123, Iss. 3, 2000-03 ,pp. : 651-652

Oxford University Press

Access to resources Recommend Favorite

Neural transplantation for the treatment of Parkinson's disease

By Bjorklund A.   Dunnett S.B.   Brundin P.   Stoessl A.J.   Freed C.R.   Breeze R.E.   Levivier M.   Peschanski M.   Studer L.   Barker R.  

Lancet Neurology, Vol. 2, Iss. 7, 2003-07 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

The potential of GDNF as a treatment for Parkinson's disease

By Hurelbrink C.B.   Barker R.A.  

Experimental Neurology, Vol. 185, Iss. 1, 2004-01 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Perispinal Etanercept for Treatment of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 4, Iss. 5, 2007-01 ,pp. : 550-552

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease: Pharmacological Treatment and Management

By Rivas-Vazquez Rafael A.   Carrazana Enrique J.   Rey Gustavo J.   Blais Mark A.   Racher David A.  

The Clinical Neuropsychologist (Neuropsychology, Development and Cognition: Sec, Vol. 14, Iss. 1, 2000-02 ,pp. : 93-109

Routledge Ltd

Access to resources Recommend Favorite